Department of Bariatric and Metabolic Surgery, China-Japan Union Hospital, Jilin University, No. 126 Xiantai Avenue, Changchun, 130033, Jilin, China.
Sci Rep. 2024 May 7;14(1):10451. doi: 10.1038/s41598-024-60983-x.
This study aimed to retrospectively analyze the perioperative and postoperative follow-up data of patients with super obesity who had undergone RYGB, SG, BPD/DS, and SADI-S. A retrospective observational study was conducted to analyze the perioperative and postoperative follow-up data of 60 patients with super obesity who had undergone bariatric surgery. A total of 34 men and 26 women were included in this study. The participants had an average preoperative BMI of 53.81 ± 3.25 kg/m. The body weight and BMI of all four patient groups decreased significantly at 3, 6, and 12 months postoperatively compared with the preoperative values. Additionally, the TWL (%) and EWL (%) of all four groups increased gradually over the same period. Compared with the preoperative values, the systolic and diastolic blood pressure, glycosylated hemoglobin, uric acid, triglycerides, and total cholesterol decreased to varying degrees in the four groups 1 year postoperatively. RYGB, SG, BPD/DS, and SADI-S are all safe and effective in treating super obese patients and improving their metabolic diseases to a certain extent.
本研究旨在回顾性分析接受 RYGB、SG、BPD/DS 和 SADI-S 治疗的超级肥胖患者的围手术期和术后随访数据。一项回顾性观察研究分析了 60 例接受减重手术的超级肥胖患者的围手术期和术后随访数据。共有 34 名男性和 26 名女性参与了这项研究。参与者术前 BMI 的平均值为 53.81 ± 3.25kg/m²。与术前相比，所有四个患者组在术后 3、6 和 12 个月时的体重和 BMI 均显著下降。此外，所有四个组的 TWL（%）和 EWL（%）在同一时期内逐渐增加。与术前相比，四个组的收缩压和舒张压、糖化血红蛋白、尿酸、甘油三酯和总胆固醇在术后 1 年均有不同程度的下降。RYGB、SG、BPD/DS 和 SADI-S 均能安全有效地治疗超级肥胖患者，并在一定程度上改善其代谢疾病。
